Cyclotides — ultra-stable circular peptides from plants — can serve as frameworks for creating oral peptide drugs or as natural libraries for discovering new therapeutic candidates.
2 approachesCyclotides advance drug discovery as both scaffolds for stabilizing therapeutic peptides and as natural combinatorial libraries
What the researchers found
Cyclotides have emerged as powerful tools in drug discovery through two principal approaches: (1) as scaffolds in which bioactive peptides can be grafted to improve stability, oral bioactivity, and binding to G-protein coupled receptors (GPCRs), and (2) as natural combinatorial peptide libraries for screening. Their unique circular structure with a cystine knot makes them exceptionally stable compared to linear peptides.
Why it matters
One of the biggest problems in peptide drug development is that peptides break down quickly in the body and can't usually be taken by mouth. Cyclotides — naturally circular, ultra-stable peptides from plants — offer a solution: you can insert therapeutic peptide sequences into their framework and they survive digestion, opening the door to oral peptide drugs.
How the study worked
This is a perspective review examining the current state of cyclotide research in drug discovery. The authors surveyed published work on two main applications: using cyclotides as scaffolds to stabilize bioactive peptides, and using them as natural peptide libraries for identifying new drug candidates.
Who was studied
Not applicable (perspective review of cyclotide drug discovery research)
What this study cannot tell us
As a brief perspective review, this paper does not present original experimental data. It provides a high-level overview rather than a systematic analysis of the literature. Specific clinical applications of cyclotide scaffolds remain theoretical at the time of writing.
How to read the evidence
This is a brief perspective review providing conceptual framing rather than experimental data. It summarizes the field's direction but does not offer new evidence.
When this study was published
Published in 2015, this review captures an early-to-mid stage of cyclotide drug discovery research. The field has advanced significantly since, with more grafting studies and structural characterizations published.
The bigger picture
The peptide drug field has long been limited by stability and oral delivery challenges. Cyclotides represent one of the most promising natural solutions — a ready-made framework that evolution has optimized for stability. If cyclotide scaffolding works at scale, it could transform peptide therapeutics from injection-only medicines into pills.
Questions still open
- How many different therapeutic peptides can be successfully grafted into cyclotide scaffolds without disrupting their stability?
- Will cyclotide-based oral peptide drugs trigger immune responses with repeated dosing?
- Can cyclotide scaffolds be produced at industrial scale cost-effectively?
Common questions
What makes cyclotides so stable compared to other peptides?
Could cyclotides lead to peptide drugs you can take as a pill?
Read the original research
Cyclotides: a natural combinatorial peptide library or a bioactive sequence player?
Journal of enzyme inhibition and medicinal chemistry, 30(4), 575-80
Citation
Mollica, Adriano; Costante, Roberto; Stefanucci, Azzurra; Novellino, Ettore. (2015). Cyclotides: a natural combinatorial peptide library or a bioactive sequence player?. Journal of enzyme inhibition and medicinal chemistry, 30(4), 575-80. https://doi.org/10.3109/14756366.2014.954108